Globus Medical Inc.
88.01
0.83 (0.95%)
At close: Jan 14, 2025, 3:59 PM
88.18
0.19%
After-hours Jan 14, 2025, 07:00 PM EST
undefined%
Bid 75
Market Cap 11.98B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0.62
PE Ratio (ttm) 141.95
Forward PE n/a
Analyst Buy
Ask 92
Volume 872,800
Avg. Volume (20D) 1,004,785
Open 87.55
Previous Close 87.18
Day's Range 86.45 - 88.52
52-Week Range 49.33 - 90.48
Beta undefined

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion p...

Sector Healthcare
IPO Date Aug 3, 2012
Employees 5,000
Stock Exchange NYSE
Ticker Symbol GMED

Analyst Forecast

According to 12 analyst ratings, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $94, which is an increase of 6.81% from the latest price.

Buy 75.00%
Hold 25.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Globus Medical Inc. is scheduled to release its earnings on Feb 20, 2025, after market closes.
Analysts project revenue of $642.82M, reflecting a 4.26% YoY growth and earnings per share of 0.73, making a 21.67% increase YoY.
2 months ago · Source
+9.43%
Globus Medical shares are trading higher after the... Unlock content with Pro Subscription
2 months ago · Source
+1.15%
Globus Medical shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates.